Product Benefits
| Core Benefit | Mechanism |
| Superior Glycemic Control | Combines the actions of decreasing glucose output/increasing sensitivity (Metformin) with increasing glucose removal via the urine (Dapagliflozin) for potent, complimentary blood sugar lowering. |
| Proven Cardio-Renal Benefits | Dapagliflozin is proven to reduce the risk of hospitalization for heart failure and slow the progression of chronic kidney disease in diabetic patients, offering vital long-term protection. |
| Modest Weight Reduction | The glucose excretion caused by Dapagliflozin leads to calorie loss, often resulting in modest but beneficial weight reduction. |
| Low Risk of Hypoglycemia | When used without insulin or sulfonylureas, the therapy carries a low intrinsic risk of dangerously low blood sugar, as Metformin and Dapagliflozin do not directly stimulate insulin release. |
⚠️ Important Safety Note: Dual Component Warnings
Prescription Required: This medication must be taken strictly as prescribed.
Lactic Acidosis Risk (Metformin): Metformin carries a rare but serious risk of Lactic Acidosis, especially in patients with kidney impairment.
11 Seek immediate medical attention if you experience unusual muscle pain, difficulty breathing, or severe stomach pain.Diabetic Ketoacidosis ($\text{DKA}$) Risk (Dapagliflozin): Dapagliflozin can cause
12 $\text{DKA}$ even with normal blood sugar levels (euglycemic13 $\text{DKA}$).14 Symptoms include nausea, vomiting, and confusion. Report these immediately.Genital/$\text{UTI}$ Risk: Due to glucose in the urine, Dapagliflozin increases the risk of genital yeast infections and urinary tract infections ($\text{UTIs}$). Maintain strict hygiene and monitor for symptoms.
Offer Products
Face Care
Hair Care
stationery & office
Tea & Coffee
Baby Wipes
Cream
Baby Essentials
Fragrances
Lip Care
Body Care
Air Freshener
Customer questions & answers
Customer reviews
0 out of 5